share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
SEC announcement ·  04/04 11:15
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 40,000 Class A shares on 04/04/2024, with an aggregate market value of $360,800. The shares to be sold were acquired through stock option exercises on various dates, with the most recent being on 07/12/2023. Gibson's acquisition of these shares was through cash payments to the issuer. This planned sale follows a series of transactions over the past three months, where a total of 239,591 shares were sold for gross proceeds of approximately $2.4 million.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 40,000 Class A shares on 04/04/2024, with an aggregate market value of $360,800. The shares to be sold were acquired through stock option exercises on various dates, with the most recent being on 07/12/2023. Gibson's acquisition of these shares was through cash payments to the issuer. This planned sale follows a series of transactions over the past three months, where a total of 239,591 shares were sold for gross proceeds of approximately $2.4 million.
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定於2024年4月4日出售4萬股A類股票，總市值爲360,800美元。待售股票是在不同的日期通過股票期權行使收購的，最近一次是在2023年12月7日。吉布森通過向發行人支付現金收購這些股份。此次計劃出售是在過去三個月進行的一系列交易之後進行的，共出售了239591股股票，總收益約爲240萬美元。
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定於2024年4月4日出售4萬股A類股票，總市值爲360,800美元。待售股票是在不同的日期通過股票期權行使收購的，最近一次是在2023年12月7日。吉布森通過向發行人支付現金收購這些股份。此次計劃出售是在過去三個月進行的一系列交易之後進行的，共出售了239591股股票，總收益約爲240萬美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息